Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wölfler

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Wiener Klinische Wochenschrift|January 24, 1998
[Interaction of the epiphysis and the immune system]P M Liebmann, A Wölfler, K Schauenstein
Life Sciences|September 12, 1998
Lack of calmodulin antagonism of melatonin in T-lymphocyte activationA Wölfler, K Schauenstein, P M Liebmann
British Journal of Pharmacology|November 3, 2010
Therapy-related myeloid neoplasms: pathobiology and clinical characteristicsH Sill, W Olipitz, A Zebisch, et al.
Leukemia|February 19, 2013
Mutant DNMT3A in acute myeloid leukemia: guilty of inducing genetic instability?A Zebisch, G Hoefler, F Quehenberger, et al.
FEBS Letters|May 25, 1999
N-acetylserotonin is a better extra- and intracellular antioxidant than melatoninA Wölfler, P M Abuja, K Schauenstein, et al.
Leukemia|November 30, 2016
Response to Harrison et al. 'Clinically relevant differences between BCSH and WHO diagnostic criteria for ET'H Gisslinger, G Jeryczynski, A Wölfler, et al.
International Archives of Allergy and Immunology|March 1, 1997
Melatonin and the immune systemP M Liebmann, A Wölfler, P Felsner, et al.
Journal of Neuroimmunology|July 1, 1996
Beta-blockade enhances adrenergic immunosuppression in rats via inhibition of melatonin releaseP M Liebmann, D Hofer, P Felsner, et al.
Developmental Immunology|November 14, 1998
Adrenergic/cholinergic immunomodulation in the rat model--in vivo veritas?I Rinner, P Felsner, P M Liebmann, et al.
FEBS Letters|October 5, 2001
Prooxidant activity of melatonin promotes fas-induced cell death in human leukemic Jurkat cellsA Wölfler, H C Caluba, P M Abuja, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Wiener Klinische Wochenschrift|January 24, 1998
[Interaction of the epiphysis and the immune system]P M Liebmann, A Wölfler, K Schauenstein
Life Sciences|September 12, 1998
Lack of calmodulin antagonism of melatonin in T-lymphocyte activationA Wölfler, K Schauenstein, P M Liebmann
British Journal of Pharmacology|November 3, 2010
Therapy-related myeloid neoplasms: pathobiology and clinical characteristicsH Sill, W Olipitz, A Zebisch, et al.
Leukemia|February 19, 2013
Mutant DNMT3A in acute myeloid leukemia: guilty of inducing genetic instability?A Zebisch, G Hoefler, F Quehenberger, et al.
FEBS Letters|May 25, 1999
N-acetylserotonin is a better extra- and intracellular antioxidant than melatoninA Wölfler, P M Abuja, K Schauenstein, et al.
Leukemia|November 30, 2016
Response to Harrison et al. 'Clinically relevant differences between BCSH and WHO diagnostic criteria for ET'H Gisslinger, G Jeryczynski, A Wölfler, et al.
International Archives of Allergy and Immunology|March 1, 1997
Melatonin and the immune systemP M Liebmann, A Wölfler, P Felsner, et al.
Journal of Neuroimmunology|July 1, 1996
Beta-blockade enhances adrenergic immunosuppression in rats via inhibition of melatonin releaseP M Liebmann, D Hofer, P Felsner, et al.
Developmental Immunology|November 14, 1998
Adrenergic/cholinergic immunomodulation in the rat model--in vivo veritas?I Rinner, P Felsner, P M Liebmann, et al.
FEBS Letters|October 5, 2001
Prooxidant activity of melatonin promotes fas-induced cell death in human leukemic Jurkat cellsA Wölfler, H C Caluba, P M Abuja, et al.
Pageof 3